Youjin Je

Summary

Affiliation: Harvard University
Country: USA

Publications

  1. ncbi Coffee consumption and risk of colorectal cancer: a systematic review and meta-analysis of prospective cohort studies
    Youjin Je
    Department of Nutrition, Harvard School of Public Health, Boston, MA, USA
    Int J Cancer 124:1662-8. 2009
  2. ncbi Coffee consumption and risk of endometrial cancer: findings from a large up-to-date meta-analysis
    Youjin Je
    Department of Nutrition, Harvard School of Public Health, Boston, MA, USA
    Int J Cancer 131:1700-10. 2012
  3. ncbi A prospective cohort study of coffee consumption and risk of endometrial cancer over a 26-year follow-up
    Youjin Je
    Department of Nutrition, Harvard School of Public Health, Boston, MA 02115, USA
    Cancer Epidemiol Biomarkers Prev 20:2487-95. 2011
  4. ncbi Meta-analysis of randomized controlled trials for the incidence and risk of treatment-related mortality in patients with cancer treated with vascular endothelial growth factor tyrosine kinase inhibitors
    Fabio A B Schutz
    Dana Farber Cancer Institute, Brigham and Women s Hospital and Harvard Medical School, Boston, MA 02215 5415, USA
    J Clin Oncol 30:871-7. 2012
  5. ncbi Risk of arterial thromboembolic events with sunitinib and sorafenib: a systematic review and meta-analysis of clinical trials
    Toni K Choueiri
    Lank Center for Genitourinary Oncology, Dana Farber Cancer Institute Brigham and Women s Hospital, Harvard Medical School, 44 Binney St Dana 1230, Boston, MA 02115, USA
    J Clin Oncol 28:2280-5. 2010
  6. ncbi Incidence and risk of congestive heart failure in patients with renal and nonrenal cell carcinoma treated with sunitinib
    Christopher J Richards
    Dana Farber Cancer Institute, Brigham and Women s Hospital and Harvard Medical School, Boston, MA, USA
    J Clin Oncol 29:3450-6. 2011
  7. ncbi Hematologic toxicities in cancer patients treated with the multi-tyrosine kinase sorafenib: a meta-analysis of clinical trials
    Fabio A B Schutz
    Kidney Cancer Center, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
    Crit Rev Oncol Hematol 80:291-300. 2011
  8. ncbi Prospective cohort studies of vitamin B-6 intake and colorectal cancer incidence: modification by time?
    Xuehong Zhang
    Channing Division of Network Medicine, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, MA 02115, USA
    Am J Clin Nutr 96:874-81. 2012
  9. ncbi Haematologic toxicities associated with the addition of bevacizumab in cancer patients
    Fabio A B Schutz
    Kidney Cancer Center, Dana Farber Cancer Institute and Harvard Medical School, Boston, MA 02115, USA
    Eur J Cancer 47:1161-74. 2011
  10. ncbi Association of androgen deprivation therapy with cardiovascular death in patients with prostate cancer: a meta-analysis of randomized trials
    Paul L Nguyen
    Department of Radiation Oncology, Dana Farber Cancer Institute, Brigham and Women s Hospital, 75 Francis St, Boston, MA 02115, USA
    JAMA 306:2359-66. 2011

Detail Information

Publications11

  1. ncbi Coffee consumption and risk of colorectal cancer: a systematic review and meta-analysis of prospective cohort studies
    Youjin Je
    Department of Nutrition, Harvard School of Public Health, Boston, MA, USA
    Int J Cancer 124:1662-8. 2009
    ..Information on coffee type, its serving size, or brewing method may provide a better understanding of this reassuring result and the real role of coffee on colorectal cancer risk...
  2. ncbi Coffee consumption and risk of endometrial cancer: findings from a large up-to-date meta-analysis
    Youjin Je
    Department of Nutrition, Harvard School of Public Health, Boston, MA, USA
    Int J Cancer 131:1700-10. 2012
    ..More large studies are needed to determine subgroups to obtain more benefits from coffee drinking in relation to endometrial cancer risk...
  3. ncbi A prospective cohort study of coffee consumption and risk of endometrial cancer over a 26-year follow-up
    Youjin Je
    Department of Nutrition, Harvard School of Public Health, Boston, MA 02115, USA
    Cancer Epidemiol Biomarkers Prev 20:2487-95. 2011
    ..Coffee has been reported to lower levels of estrogen and insulin, two hormones implicated in endometrial carcinogenesis, but prospective data on the relation between coffee consumption and risk of endometrial cancer are limited...
  4. ncbi Meta-analysis of randomized controlled trials for the incidence and risk of treatment-related mortality in patients with cancer treated with vascular endothelial growth factor tyrosine kinase inhibitors
    Fabio A B Schutz
    Dana Farber Cancer Institute, Brigham and Women s Hospital and Harvard Medical School, Boston, MA 02215 5415, USA
    J Clin Oncol 30:871-7. 2012
    ..We performed an up-to-date meta-analysis to determine the risk of fatal adverse events (FAEs) in patients with cancer treated with VEGFR TKIs...
  5. ncbi Risk of arterial thromboembolic events with sunitinib and sorafenib: a systematic review and meta-analysis of clinical trials
    Toni K Choueiri
    Lank Center for Genitourinary Oncology, Dana Farber Cancer Institute Brigham and Women s Hospital, Harvard Medical School, 44 Binney St Dana 1230, Boston, MA 02115, USA
    J Clin Oncol 28:2280-5. 2010
    ..We did a systematic review and meta-analysis to determine the incidence and the relative risk (RR) associated with the use of sunitinib and sorafenib...
  6. ncbi Incidence and risk of congestive heart failure in patients with renal and nonrenal cell carcinoma treated with sunitinib
    Christopher J Richards
    Dana Farber Cancer Institute, Brigham and Women s Hospital and Harvard Medical School, Boston, MA, USA
    J Clin Oncol 29:3450-6. 2011
    ..We performed an up-to-date meta-analysis to determine the risk of developing CHF in patients with both RCC and non-RCC tumors treated with sunitinib...
  7. ncbi Hematologic toxicities in cancer patients treated with the multi-tyrosine kinase sorafenib: a meta-analysis of clinical trials
    Fabio A B Schutz
    Kidney Cancer Center, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
    Crit Rev Oncol Hematol 80:291-300. 2011
    ..We performed a meta-analysis to determine the incidence and risk of hematologic toxicities associated with sorafenib use...
  8. ncbi Prospective cohort studies of vitamin B-6 intake and colorectal cancer incidence: modification by time?
    Xuehong Zhang
    Channing Division of Network Medicine, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, MA 02115, USA
    Am J Clin Nutr 96:874-81. 2012
    ..The relation between vitamin B-6 intake and colorectal cancer risk remains uncertain...
  9. ncbi Haematologic toxicities associated with the addition of bevacizumab in cancer patients
    Fabio A B Schutz
    Kidney Cancer Center, Dana Farber Cancer Institute and Harvard Medical School, Boston, MA 02115, USA
    Eur J Cancer 47:1161-74. 2011
    ..We performed a meta-analysis to determine the incidence and risk of haematologic toxicities associated with bevacizumab...
  10. ncbi Association of androgen deprivation therapy with cardiovascular death in patients with prostate cancer: a meta-analysis of randomized trials
    Paul L Nguyen
    Department of Radiation Oncology, Dana Farber Cancer Institute, Brigham and Women s Hospital, 75 Francis St, Boston, MA 02115, USA
    JAMA 306:2359-66. 2011
    ....
  11. ncbi Risk of bleeding with vascular endothelial growth factor receptor tyrosine-kinase inhibitors sunitinib and sorafenib: a systematic review and meta-analysis of clinical trials
    Youjin Je
    Department of Nutrition, Harvard School of Public Health, Boston, MA 02115, USA
    Lancet Oncol 10:967-74. 2009
    ..Bleeding has been described with these agents, although the overall risk remains unclear. We did a systematic review and meta-analysis to calculate the incidence and relative risk associated with use of sunitinib and sorafenib...